Authors
|
Year
|
Title
|
Journal and link to the article
|
Christoph H. Emmerich et al.
|
2020 |
Improving target assessment in biomedical research: the GOT-IT recommendations
|
Nature Reviews Drug Discovery
|
Bespalov et al.
|
2019
|
Be positive about negatives–recommendations for the publication of negative (or null) results
|
European Neuropsychopharmacology
|
Arroyo-Araujo et al. |
2019 |
Reproducibility via coordinated standardization: a multi-center study in a Shank2 genetic rat model for Autism Spectrum Disorders |
Scientific Reports |
Prager et al.
|
2018 |
Improving transparency and scientific rigor in academic publishing
|
Improving transparency and scientific rigor in academic publishing |
Bespalov et al.
|
2018 |
Industry is more alarmed about reproducibility than academia
|
Nature
|
Bespalov & Steckler
|
2018 |
Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?
|
Journal of Neuroscience Methods |
Kokras et al.
|
2017
|
Kinoscope: An Open-Source Computer Program for Behavioral Pharmacologists.
|
Frontiers in Behavioral Neuroscience
|
Bespalov et al. |
2016 |
Failed clinical trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets.
|
Nature Reviews Drug Discovery
|
Popp et al.
|
2016 |
In search of the mechanisms of ketamine’s antidepressant effects: How robust is the evidence behind the mTor activation hypothesis. |
F1000Research |
Steckler et al.
|
2016 |
Reporting guidelines for Psychopharmacology
|
Psychopharmacology |
Steckler et al. |
2015 |
The Preclinical Data Forum Network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience. |
European Neuropsychopharmacology |
Steckler |
2015 |
Preclinical data reproducibility for R&D - the challenge for neuroscience |
Psychopharmacology |